Press release
28.10.2022 To the attention of interested persons EMA recommends measures to minimise risk of serious side effects with Janus kinase […]
Press release
28.10.2022 To the attention of interested persons EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines download document …
Important notification
14.10.2022 To the attention of medical devices manufacturers and all stakeholders On 13.10.2022, Emergency ordinance regarding the setup of an […]
Important notification
10.10.2022 To the attention of manufacturers of custom-made devices, based in Romania Please be informed that Order No. 2845 of […]
Important notification
04.10.2022 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Important notification
04.10.2022 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Press release
30.09.2022 To the attention of interested persons New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome download document […]
Important notification
19.09.2022 To the attention of manufacturers of in vitro diagnostic medical devices, economic operators, notified bodies and all stakeholders Please […]
Important notification
19.09.2022 To the attention of manufacturers of in vitro diagnostic medical devices, economic operators, notified bodies and all stakeholders Please […]
Important notification
14.09.2022 To the attention of interested persons To the attention of economic operators (OE) requesting approval for importing medical devices, […]